Search

Search Constraints

You searched for: Author/Creator Woessner, Richard

Search Results

1. BLU-701 tumour suppression and intracranial activity as a single agent and in combination with BLU-945 in models of non-small cell lung cancer (NSCLC) driven by EGFR mutations. (March 2022)

2. Conversion of ATP to adenosine by CD39 and CD73 in multiple myeloma can be successfully targeted together with adenosine receptor A2A blockade. Issue 1 (14th May 2020)

3. Identification of azabenzimidazoles as potent JAK1 selective inhibitors. Issue 1 (1st January 2016)

7. Small molecule AZD4635 inhibitor of A2AR signaling rescues immune cell function including CD103+ dendritic cells enhancing anti-tumor immunity. Issue 2 (29th July 2020)

8. STAT3 antisense oligonucleotide AZD9150 in a subset of patients with heavily pretreated lymphoma: results of a phase 1b trial. Issue 1 (16th November 2018)

9. STAT3 Modulation of Regulatory T Cells in Response to Radiation Therapy in Head and Neck Cancer. (13th March 2019)